Impact of a protein supplement on infant growth in Southern Nepal
Balanced Energy Protein Supplement in Early Lactation on Infant Growth in Southern Nepal
This study is looking at how a special protein supplement can help undernourished pregnant women and new moms support their babies' growth in the first six months of life, aiming to find ways to improve nutrition for families in need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10886065 on NIH RePORTER |
What this research studies
This research investigates how a balanced energy protein supplement can improve the growth of infants during the first six months of life when given to undernourished women during pregnancy and lactation. The study will evaluate the effects of this supplement on both maternal nutritional status and infant growth outcomes. Additionally, it will explore the relationships between maternal and infant nutrient levels, inflammation, and the composition of breast milk. The goal is to identify effective nutritional interventions that can help break the cycle of malnutrition in low-and-middle income countries.
Who could benefit from this research
Good fit: Ideal candidates for this research are undernourished pregnant or lactating women in Southern Nepal.
Not a fit: Patients who are not pregnant or lactating, or those who are not undernourished, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved growth and health outcomes for infants born to undernourished mothers.
How similar studies have performed: Previous research has shown that nutritional interventions during pregnancy and lactation can significantly improve infant health outcomes, suggesting a promising avenue for this study.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Erchick, Daniel Joseph — Johns Hopkins University
- Study coordinator: Erchick, Daniel Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.